Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An acute lymphoblastic leukemia of T-cell origin occurring in children.
Biomarker and diagnostic research for T-cell childhood acute lymphocytic leukemia has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE3, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
286 publications have been identified in PubMed for T-cell childhood acute lymphocytic leukemia. Research spans Basic Science / Preclinical (31%), Review / Meta-Analysis (21%), and Clinical Trial Publication (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 90 |
Data assembled from 3 of 12 sources · Last updated Oct 4, 2026, 6:18 AM UTC
31%
Research summaries | 60 | 21% |
Clinical study results | 37 | 13% |
New treatment approaches | 34 | 12% |
Disease patterns and progression | 27 | 9% |
Testing and diagnosis research | 21 | 7% |
Patient case studies | 13 | 5% |
Other research | 4 | 1% |
Liu M (2026). [PMID: 41638199](https://pubmed.ncbi.nlm.nih.gov/41638199/). *Cell Rep Med*. [Basic Science / Preclinical]
Dreyzin A (2026). [PMID: 41411486](https://pubmed.ncbi.nlm.nih.gov/41411486/). *Blood Adv*. [Clinical Trial Publication]
Tang G (2026). [PMID: 41581705](https://pubmed.ncbi.nlm.nih.gov/41581705/). *Hum Pathol*. [Basic Science / Preclinical]
Deimundo Roura C (2026). [PMID: 41176033](https://pubmed.ncbi.nlm.nih.gov/41176033/). *Transplant Cell Ther*. [Review / Meta-Analysis]
Dreyzin A (2026). [PMID: 41190967](https://pubmed.ncbi.nlm.nih.gov/41190967/). *Cytotherapy*. [Diagnostic / Biomarker]
Kim HY (2026). [PMID: 41093603](https://pubmed.ncbi.nlm.nih.gov/41093603/). *Ann Lab Med*. [Diagnostic / Biomarker]
Goldberg L (2026). [PMID: 41720802](https://pubmed.ncbi.nlm.nih.gov/41720802/). *Nat Commun*. [Basic Science / Preclinical]
Xu Y (2026). [PMID: 41851457](https://pubmed.ncbi.nlm.nih.gov/41851457/). *Nature*. [Basic Science / Preclinical]
Syed YY (2026). [PMID: 41697594](https://pubmed.ncbi.nlm.nih.gov/41697594/). *Paediatr Drugs*. [Review / Meta-Analysis]
Vieira Martins M (2026). [PMID: 41505662](https://pubmed.ncbi.nlm.nih.gov/41505662/). *J Clin Oncol*. [Gene Therapy / Novel Therapeutics]